After knockdown ofIMPA2, the IC50 values of paclitaxel were decreased in both HeLa and SiHa cells (Figure 5C,D), indicating that inhibition of IMPA2 expression could enhance the sensitivity of tumor cells to paclitaxel. The gene discussed is IMPA2; the disease is neoplasm.